Doug Besch Optimize Rx Corp (OPRX) insider trading activity

Doug Besch is Chief Product & Tech Officer of OptimizeRx Corp. Currently has a direct ownership of 66,876 shares of OPRX, which is worth approximately $1.02 Million. The most recent transaction as insider was on Dec 23, 2025, when has been sold 4,079 shares (Common Stock) at a price of $12.74 per share, resulting in proceeds of $51,966. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 66.9K

3.88% 3M change

26.2% 12M change

Total Value Held $1.02 Million

Doug Besch Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 23 2025	SELL Payment of exercise price or tax liability	$51,966 $12.74 p/Share	4,079 Reduced 5.75%	66,876 Common Stock
Dec 19 2025	SELL Payment of exercise price or tax liability	$7,849 $13.51 p/Share	581 Reduced 0.81%	70,955 Common Stock
Dec 19 2025	BUY Exercise of conversion of derivative security	-	1,964 Added 2.67%	71,536 Common Stock
Oct 03 2025	SELL Payment of exercise price or tax liability	$18,431 $18.75 p/Share	983 Reduced 1.39%	69,572 Common Stock
Oct 03 2025	BUY Exercise of conversion of derivative security	-	3,325 Added 4.5%	70,555 Common Stock
Aug 21 2025	BUY Grant, award, or other acquisition	-	15,625 Added 18.86%	67,230 Common Stock
Feb 15 2025	SELL Payment of exercise price or tax liability	$9,203 $6.64 p/Share	1,386 Reduced 2.62%	51,605 Common Stock

Dec 23 2024	BUY Grant, award, or other acquisition	-	41,408 Added 43.86%	52,991 Common Stock
Dec 19 2024	SELL Payment of exercise price or tax liability	$2,740 $4.75 p/Share	577 Reduced 4.75%	11,583 Common Stock
Dec 19 2024	BUY Exercise of conversion of derivative security	-	1,964 Added 13.91%	12,160 Common Stock
Oct 03 2024	SELL Payment of exercise price or tax liability	$7,642 $7.83 p/Share	976 Reduced 8.74%	10,196 Common Stock
Oct 03 2024	BUY Exercise of conversion of derivative security	-	3,324 Added 22.93%	11,172 Common Stock
Feb 15 2024	BUY Grant, award, or other acquisition	-	4,000 Added 33.76%	7,848 Common Stock
Oct 03 2023	SELL Payment of exercise price or tax liability	$6,890 $7.06 p/Share	976 Reduced 20.23%	3,848 Common Stock
Oct 03 2023	BUY Exercise of conversion of derivative security	-	3,324 Added 40.8%	4,824 Common Stock

Doug Besch

Chief Product & Tech Officer

Rochester, MI

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OPRX shares.

Notify only if

Value

Insider Trading

Get notified when an Optimize Rx Corp insider buys or sells OPRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to OptimizeRx Corp

Track Activities on OPRX

Account